IMCR
Immunocore Holdings plc American Depositary Shares (IMCR)
$
56About Immunocore Holdings plc American Depositary Shares (IMCR)
Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease. Its lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma, in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. The company was founded on January 7, 2021 and is headquartered in Abingdon, the United Kingdom.
Details
Daily high
$29.78
Daily low
$28.10
Price at open
$28.27
52 Week High
$73.16
52 Week Low
$27.69
Market cap
1.5B
Dividend yield
0.00%
Volume
138,968
Avg. volume
186,343
P/E ratio
-30.89
Immunocore Holdings plc American Depositary Shares News
Details
Daily high
$29.78
Daily low
$28.10
Price at open
$28.27
52 Week High
$73.16
52 Week Low
$27.69
Market cap
1.5B
Dividend yield
0.00%
Volume
138,968
Avg. volume
186,343
P/E ratio
-30.89